AtriCure Inc. (A5I)
FSX
Closed
Oct 7, 2026
Day's Range
47.2052 wk Range
21.80Overview - A5I - AtriCure Inc.
Key Statistics
Valuation
Enterprise Value
2.08B
P/E (Trailing)
‪252.63‬
P/E (Forward)
‪-63.91‬
PEG Ratio
‪-1.05‬
Price / Sales (TTM)
‪4.28‬
Price / Book
‪5.42‬
EV / EBITDA
‪69.57‬
Profitability
Gross Margin
‪77.23%‬
Profit Margin
‪1.85%‬
Operating Margin
‪6.29%‬
Return on Assets
‪1.25%‬
Return on Equity
‪2.15%‬
Ownership
Shares Outstanding
50.86M
Float
48.82M
Held by Insiders
‪3.75%‬
Held by Institutions
‪105.82%‬
Price stats
Beta
‪1.26‬
50-Day Avg
‪42.26‬
200-Day Avg
‪30.63‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - A5I - AtriCure Inc.
Peers - A5I - AtriCure Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
Profile Summary - A5I - AtriCure Inc.
About
AtriCure Inc. is a medical device company that develops and sells surgical technologies for treating atrial fibrillation, managing the left atrial appendage, and controlling post-operative pain. Its portfolio includes ablation systems, left atrial appendage exclusion devices, cryoablation products, and related…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
